HCW Biologics Inc Forecast, price target & analysts
HCW Biologics Inc Target price 2026 - Analyst rating & recommendation
HCW Biologics Inc Classifications & Recommendation
HCW Biologics Inc Price Target
| Target Price | $30.60 |
| Price | $1.75 |
| Potential |
1,648.57%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target HCW Biologics Inc 2027 .
The average HCW Biologics Inc target price is $30.60.
This is
1,648.57%
register free of charge
$31.50
1,700.00%
register free of charge
$30.30
1,631.43%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend HCW Biologics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HCW Biologics Inc stock has an average upside potential 2027 of
1,648.57%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.05 | 6.67 |
| 98.05% | 13,248.00% | |
| Net Margin | -44,600.00% | -71.31% |
| 3,718.19% | 99.84% |
3 Analysts have issued a sales forecast HCW Biologics Inc 2026 . The average HCW Biologics Inc sales estimate is
This results in the following potential growth metrics:
3 HCW Biologics Inc Analysts have issued a net profit forecast 2026. The average HCW Biologics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Margin
| 2025 | -44,600.00% | 3,718.19% |
|---|---|---|
| 2026 |
-71.31%
99.84%
unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -63.78 | -2.94 |
| 65.66% | 95.39% | |
| P/E | negative | |
| EV/Sales | 1.46 |
3 Analysts have issued a HCW Biologics Inc forecast for earnings per share. The average HCW Biologics Inc EPS is
This results in the following potential growth metrics and future valuations:
HCW Biologics Inc...
Current HCW Biologics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | May 28 2026 |
| Maxim Group |
Locked
➜
Locked
|
Locked | May 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
May 28 2026 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
May 29 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
